STAT+: RevMed’s pancreatic cancer drug nears European approval
STAT News · LC · trust 30/100
Following a green light from the FDA, European regulators have now recommended the approval of Revolution Medicines' Rasonque for pancreatic cancer.
Read the original at STAT News →
Open in TruthVane →